Abbott's FreeStyle Libre CGM systems include sensors intended for placement on the back of the upper arm. The sensors may be ...

The recall does not affect users outside the U.S. or those using other FreeStyle Libre products such as the FreeStyle Libre ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 ...

Worldwide sales of the Freestyle Libre grew exponentially in 2019 ... Sarah, 42, from Northampton, has had Type 1 diabetes since she was 14. She has been back on finger prick testing for a ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as ... every minute directly to the user's smartphone for up to 14 days, allowing them to adjust treatment as needed.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

Among the many corporations that pay a dividend, some do so unpredictably and irregularly. Others rarely raise their payouts ...

Some better-ranked stocks in the broader medical space are TransMedix Group TMDX, Veracyte VCYT and Boston Scientific BSX. While TransMedix Group and Veracyte currently sport a Zacks Rank #1 (Strong ...

The next generation of the company’s continuous glucose monitoring system is small, thin and can be worn for up to 14 days ... have used Abbott’s FreeStyle Libre portfolio, according to ...

Four years later they launched FreeStyle Libre, a reimagined continuous glucose monitoring (CGM) system in which an even smaller sensor applied to a patient’s arm sends data directly to a ...